Clinical trials
Cord Blood clinical trials
Below are recruiting cord blood clinical trials, each written for real people, not researchers. We’re tracking 98 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07441720RecruitingPhase 2
Umbilical cord blood for low platelets after cancer therapy
This trial tests whether a one-time infusion of umbilical cord blood cells can safely raise platelet counts in people whose counts dropped after cancer treatment. It is for patients whose low platelets are clearly linked to their cancer therapy and who have no other major health problems.
Hangzhou, ZhejiangAges 12–65 - NCT07110090RecruitingPhase 1
Umbilical cord blood shot for low platelets after cancer treatment
This trial tests an injection made from umbilical cord blood to raise low platelet counts caused by cancer therapies like chemo, immunotherapy, or radiation. It may help people with mild to moderate low platelets who haven't had recent platelet transfusions or other platelet-raising drugs.
Beijing, Beijing MunicipalityAges 18–75 - NCT06830551Recruiting
Cord blood serum eye drops for severe eye problems from anti-EGFR treatment
This trial tests whether cord blood serum eye drops can help with severe dry eye or corneal damage caused by anti-EGFR cancer treatment. If you have advanced cancer with an EGFR mutation and are struggling with eye irritation or vision problems from your medication, this study might offer a new way to help.
BolognaAges 18 years+ - NCT07208344RecruitingEarly Phase 1
Umbilical cord blood infusion for Alzheimer's disease
This early-phase study tests whether infusing donated umbilical cord blood (a source of young immune cells) can help slow Alzheimer's disease. It is for people aged 50–75 with mild to moderate Alzheimer's who have a caregiver and are otherwise generally healthy.
Hefei, AnhuiAges 50–75 - NCT06848582Recruiting
NK cell therapy for high-risk pediatric soft tissue sarcoma
This trial tests whether giving immune cells called NK cells from donated umbilical cord blood can help children and teens with high-risk or returning soft tissue sarcoma. The goal is to see if it is safe and effective when other treatments have been tried.
Guangzhou, GuangdongAges Up to 18 years - NCT05584761RecruitingPhase 1/Phase 2
Cord blood stem cells plus azacitidine for advanced blood cancers
This trial tests whether adding donated cord blood stem cells to azacitidine can improve outcomes for people with advanced MDS, CMML-2, or a certain type of AML. It may help by giving the treatment a stronger chance to control abnormal blood-forming cells.
Nanjing, JiangsuAges 18–80 - NCT07010900Recruiting
Cord blood plasma injections plus stretching for Peyronie's disease
This study tests if injections of platelet-rich plasma from cord blood, combined with daily penis stretching, works better than stretching alone to treat Peyronie's disease (curved erections). It may help men with moderate to severe curvature who haven't had prior treatment.
MilanAges 18–75 - NCT06947473RecruitingPhase 1/Phase 2
CAR T-cell therapy for lupus, sclerosis, and Sjogren's
This trial tests a new type of immune cell therapy (CAR T-cells from umbilical cord blood) for people with certain autoimmune diseases that haven't responded to standard treatments. It aims to see if targeting two proteins (CD19 and BCMA) can help calm the overactive immune system.
Beijing, Beijing MunicipalityAges 6–65 - NCT03016806Recruiting
Umbilical cord blood transplant from unrelated donors
This trial studies transplanting healthy blood-forming cells from an umbilical cord blood donor who is not related to you. It may help people with certain blood cancers, immune disorders, or other serious diseases when a standard transplant plan is needed.
Rochester, New YorkAges 2 months–75 years - NCT06013423RecruitingPhase 2
Cord blood transplant with chemo and radiation for high-risk blood cancers
This trial tests a cord blood transplant after a reduced-intensity chemotherapy and radiation regimen for patients with high-risk blood cancers like leukemia, lymphoma, or MDS. The goal is to see if this approach can help destroy cancer cells and restore healthy blood cells.
Seattle, WashingtonAges 6 months–65 years - NCT03173937RecruitingPhase 1/Phase 2
Cord blood transplant for severe aplastic anemia or MDS
This trial tests a special type of cord blood transplant using lab-grown stem cells to help the new blood-forming cells “take” sooner. It’s for people with severe aplastic anemia or certain MDS cases who have not responded well to standard immune-suppressing treatments.
Bethesda, MarylandAges 4–75 - NCT07147296Recruiting
Implant to manage blood pressure swings after spinal cord injury
This trial tests an implanted device that may help control drops in blood pressure caused by spinal cord injury. If you often feel dizzy or lightheaded due to low blood pressure, this study could explore whether the device improves stability.
Little Rock, ArkansasAges 18–75 - NCT06650553Recruiting
Cord blood stem cell transplant for aplastic anemia
This study tests whether adding umbilical cord blood to a stem cell transplant from a half-matched donor can improve outcomes for people with severe aplastic anemia or related bone marrow failure diseases.
Taiyuan, ShanxiAges 6–75 - NCT06066359RecruitingPhase 1/Phase 2
Cord blood NK cells for NY-ESO-1 positive myeloma
This trial tests a new treatment using cord blood immune cells (NK cells) that are specially designed to target a protein called NY-ESO-1 found on myeloma cells. It is for people with multiple myeloma that has come back or not responded to at least two previous treatments.
Houston, TexasAges 18–80 - NCT06381817RecruitingPhase 3
Stem cell transplant comparison for T-cell leukemia
This study compares two types of stem cell transplants for adults with T-ALL: one using a half-matched donor alone, and one using a half-matched donor plus umbilical cord blood. The goal is to see which approach gives better results with fewer side effects.
Suzhou, JiangsuAges Any age - NCT03371641Recruiting
Study of alcohol exposure effects in unborn babies
This study looks at unborn babies exposed to alcohol during pregnancy and compares them with babies not exposed. Researchers test a pregnancy blood marker to see whether it may relate to early brain changes in the baby.
RouenAges 18 years+ - NCT04819893Recruiting
Study fatty acids and eye disease risk in newborns
This study looks at whether fatty acids from the mother are linked to the risk of retinopathy of prematurity, an eye condition that can affect very premature babies. It involves checking factors related to how the body responds to fatty acids during pregnancy and comparing mothers in different pregnancy situations.
DijonAges 18 years+ - NCT06908616Recruiting
Study of Low White Blood Cell Counts and Blood Types in Newborns
This trial looks at how common a harmless condition called ethnic neutropenia (low white blood cells) and a specific blood type (Duffy null) are in newborns at Kaplan Medical Center. It helps doctors understand normal blood cell differences across ethnic groups.
Rehovot, IsraelAges 1 minute–1 day - NCT06545227Recruiting
Early vs. Late Monitoring for Gestational Diabetes History
This study looks at whether checking blood sugar levels earlier or later in pregnancy is better for women who had gestational diabetes before. It aims to find the best time to start monitoring to help protect both mom and baby.
LondonAges 17–45 - NCT07504055Recruiting
Non-invasive spinal cord stimulation for blood pressure after injury
This study tests whether a non-invasive spinal cord stimulation device can help regulate blood pressure in people with spinal cord injury who have low blood pressure symptoms. It may help you feel less dizzy or faint when you sit or stand up.
Louisville, KentuckyAges 18 years+ - NCT07699094Recruiting
Predicting blood pressure changes in spinal cord injury
This study uses a simple finger sensor to monitor blood pressure regulation in people with spinal cord injury. It aims to find a new way to predict and manage blood pressure issues.
The Bronx, New YorkAges 18–75 - NCT05305118Recruiting
Blood pressure–focused study after fresh spinal cord injury
This study looks at a treatment approach for people with a new spinal cord injury who have unstable blood pressure. It may help the team understand how to manage blood pressure problems during early recovery.
New York, New YorkAges 18–89 - NCT06451133Recruiting
Blood pressure management after traumatic spinal cord injury
This study tests a way to manage blood pressure after a traumatic spinal cord injury. It aims to improve blood flow to the injured area and help recovery.
Houston, TexasAges 18 years+ - NCT07249099Enrolling by invitation
Cord blood bank follow-up study
This study follows people who have stored umbilical cord blood at the Tianjin Cord Blood Bank. It collects health information to learn more about cord blood storage and its future use.
Tianjin, Tianjin MunicipalityAges Any age
Hear when a new Cord Blood trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for cord blood?
- Yes. Clin2 currently lists 98 recruiting cord blood studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a cord blood trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a cord blood trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.